Variables | HR | 95% CI | P-value |
Surgical exploration vs palliative group, unadjusted | 1.02 | 0.67 - 1.57 | 0.898 |
Surgical exploration vs palliative group, adjusted for gender, presence of metastases and CRP levels >5 mg/L | 1.06 | 0.69 - 1.64 | 0.782 |